EUVIMEDEUVIMED entdecken
Crossref

Risk stratification for synchronous/metachronous recurrence after endoscopic submucosal dissection for Barrett’s esophageal adenocarcinoma using the length of Barrett’s esophagus

Yohei Ikenoyama iD, Ken Namikawa, Manabu Takamatsu, Yusuke Kumazawa, Yoshitaka Tokai, Shoichi Yoshimizu, Yusuke Horiuchi, Akiyoshi Ishiyama, Toshiyuki Yoshio, Toshiaki Hirasawa, Toru Ogura, Junko Fujisaki

Esophagus · 2024

DOI: 10.1007/s10388-024-01058-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Esophagus, 2024. Verfasst von Yohei Ikenoyama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. 0801yohei@med.mie-u.ac.jp. Hauptthemen laut MEDLINE: Barrett Esophagus, Esophageal Neoplasms, Endoscopic Mucosal Resection, Adenocarcinoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In Japan, the standard management of Barrett's esophageal adenocarcinoma after endoscopic submucosal dissection involves follow-up; however, multifocal synchronous/metachronous lesions are sometimes observed after endoscopic submucosal dissection. Risk stratification of multifocal cancer facilitates appropriate treatment, including eradication of Barrett's esophagus in high-risk cases; however, no effective risk stratification methods have been established. Thus, we identified the risk factors for multifocal cancer and explored risk-stratified treatment strategies for residual Barrett's esophagus. METHODS: We retrospectively reviewed the data of 97 consecutive patients with superficial Barrett's esophageal adenocarcinomas who underwent curative resection with endoscopic submucosal dissection. Multifocal cancer was defined by the presence of synchronous/metachronous lesions during follow-up. We used Cox regression analysis to identify the risk factors for multifocal cancer and subsequently analyzed differences in cumulative incidences. RESULTS: The cumulative incidences of multifocal cancer at 1, 3, and 5 years were 4.4%, 8.6%, and 10.7%, respectively. Significant risk factors for multifocal cancer were increased circumferential and maximal lengths of Barrett's esophagus. The cumulative incidences of multifocal cancer at 3 years were lower for patients with circumferential length < 4 cm and maximal length < 5 cm (2.9% and 1.2%, respectively) than for patients with circumferential length ≥ 4 cm and maximal length ≥ 5 cm (51.5% and 49.1%, respectively). CONCLUSIONS: Risk stratification of multifocal cancer using length of Barrett's esophagus was effective. Further multicenter prospective studies are needed to substantiate our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusEsophageal NeoplasmsEndoscopic Mucosal ResectionAdenocarcinomaNeoplasm Recurrence, LocalHumansMaleFemaleAgedRetrospective StudiesMiddle AgedRisk AssessmentRisk FactorsJapanIncidenceNeoplasms, Second PrimaryEsophagoscopyNeoplasms, Multiple PrimaryAged, 80 and over

Stichwörter der Autor:innen

AdenocarcinomaBarrett’s esophagusDisease eradicationEndoscopic submucosal dissectionMetachronous neoplasms

Autor:innen und Institutionen

  • Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. 0801yohei@med.mie-u.ac.jp.
  • Department of Gastroenterology and Hepatology, Mie University Hospital, 2-174 Edobashi, Tsu City, Mie, 514-8507, Japan. 0801yohei@med.mie-u.ac.jp.
  • Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Clinical Research Support Center, Mie University Hospital, 2-174 Edobashi, Tsu City, Mie, 514-8507, Japan.

ORCID-Profile: Yohei Ikenoyama

Zitieren

APA

Ikenoyama, Y., Namikawa, K., Takamatsu, M., Kumazawa, Y., Tokai, Y., Yoshimizu, S., Horiuchi, Y., Ishiyama, A., Yoshio, T., Hirasawa, T., Ogura, T., & Fujisaki, J. (2024). Risk stratification for synchronous/metachronous recurrence after endoscopic submucosal dissection for Barrett’s esophageal adenocarcinoma using the length of Barrett’s esophagus. Esophagus. https://doi.org/10.1007/s10388-024-01058-8

Vancouver

Ikenoyama Y, Namikawa K, Takamatsu M, Kumazawa Y, Tokai Y, Yoshimizu S, et al. Risk stratification for synchronous/metachronous recurrence after endoscopic submucosal dissection for Barrett’s esophageal adenocarcinoma using the length of Barrett’s esophagus. Esophagus. 2024. doi:10.1007/s10388-024-01058-8

BibTeX
@article{Ikenoyama2024,
  author = {Ikenoyama, Yohei and Namikawa, Ken and Takamatsu, Manabu and Kumazawa, Yusuke and Tokai, Yoshitaka and Yoshimizu, Shoichi and Horiuchi, Yusuke and Ishiyama, Akiyoshi and Yoshio, Toshiyuki and Hirasawa, Toshiaki and Ogura, Toru and Fujisaki, Junko},
  title = {Risk stratification for synchronous/metachronous recurrence after endoscopic submucosal dissection for Barrett’s esophageal adenocarcinoma using the length of Barrett’s esophagus},
  journal = {Esophagus},
  year = {2024},
  doi = {10.1007/s10388-024-01058-8}
}
Kostenlos starten →